Apple Wins Antitrust Lawsuit Over Heart Rate Apps for Apple Watch
In a major victory for Apple, a federal judge dismissed an antitrust lawsuit filed by medical device and AI company, AliveCor. The lawsuit alleged that Apple had illegally monopolized the US market for heart rate apps on the Apple Watch. The judge’s reasoning for the dismissal is currently confidential, but the decision is expected to be released soon.
Lawsuit Filed by AliveCor Claims Apple Abused Market Power
AliveCor‘s lawsuit, filed in 2021, accused Apple of using its market power to stifle competition and engage in “predatory” and “exclusionary” conduct related to the Apple Watch’s electrocardiogram (ECG) technology. While the judge’s decision is not yet known, AliveCor plans to appeal the ruling. The company also has another ongoing suit against Apple regarding the ECG sensor, which will be reviewed in the coming months.
Separate Lawsuit from Masimo’s Patent Infringement Claim
The antitrust lawsuit filed by AliveCor is separate from the patent infringement claim brought by medical tech company Masimo. The US International Trade Commission (ITC) had previously barred Apple from selling certain Apple Watch models due to the claim. Although Apple initially appealed and was granted a temporary stay, the US Court of Appeals declined to extend the stay in January 2024. Apple has since disabled the sensor and modified its watches to comply with the ban.
Last-Minute Workarounds to Avoid Breaking the Law
In order to comply with the ban imposed by the ITC, Apple has implemented last-minute workarounds. While the ban only applies directly to Apple, the company has disabled the blood oxygen sensor in the affected watches. However, customers can still purchase watches with the sensor intact from other retailers as long as supplies last. It is unclear how long these modified watches will be available for purchase.
Setback for Smaller Companies Taking on Apple
The dismissal of the antitrust lawsuit is a setback for smaller companies hoping to compete with Apple in the wearable technology market. The court’s ruling reinforces Apple’s dominance in the industry. However, it is worth noting that Apple Watch owners will not lose any functionality as a result of the lawsuit, unlike the previous dispute with Masimo. The more affordable Apple Watch SE does not have the blood oxygen sensor capability in the first place.
Stay Updated with the Best Apple Watches Guide
As new developments arise, it is important to stay informed about the best Apple Watches on the market. Despite the legal challenges, Apple’s wearable devices continue to offer a range of features and functionalities. Websites like 9to5Mac will continue to provide the latest information and guidance on the best options available to consumers.
Analyst comment
Positive news: Apple Wins Antitrust Lawsuit Over Heart Rate Apps for Apple Watch
Short analysis: The dismissal of the antitrust lawsuit is positive for Apple, reinforcing its dominance in the wearable technology market. Apple Watch owners will not lose any functionality. These legal challenges do not impact the continued availability and features of Apple’s wearable devices.
